Compile Data Set for Download or QSAR
maximum 50k data
Found 80 Enz. Inhib. hit(s) with all data for entry = 2719
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376962(US10329300, Example 50 | US11696917, Example 50 | ...)
Affinity DataIC50:  2.90nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376933(US10329300, Example 27 | US11696917, Example 27 | ...)
Affinity DataIC50:  3.90nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376912(US10329300, Example 6 | US11696917, Example 6 | US...)
Affinity DataIC50:  4nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376924(US10329300, Example 18 | US11696917, Example 18 | ...)
Affinity DataIC50:  4.40nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376920(US10329300, Example 14 | US11696917, Example 14 | ...)
Affinity DataIC50:  4.60nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376988(US10329300, Example 76 | US11696917, Example 76 | ...)
Affinity DataIC50:  5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376948(US10329300, Example 36 | US11696917, Example 36 | ...)
Affinity DataIC50:  5.40nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376923(US10329300, Example 17 | US11696917, Example 17 | ...)
Affinity DataIC50:  5.90nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376945((R)-4-(1-(1-acryloylpiperidin-3-yl)-4-amino-1H-pyr...)
Affinity DataIC50:  6nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376941(US10329300, Example 29 | US11696917, Example 29 | ...)
Affinity DataIC50:  6.5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376932(US10329300, Example 26 | US11696917, Example 26 | ...)
Affinity DataIC50:  7nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376909(US10329300, Example 3 | US9920060, 3)
Affinity DataIC50:  7.10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376913(US10329300, Example 7 | US11696917, Example 7 | US...)
Affinity DataIC50:  7.10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376918(US10329300, Example 12 | US11696917, Example 12 | ...)
Affinity DataIC50:  7.5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376917(US10329300, Example 11 | US11696917, Example 11 | ...)
Affinity DataIC50:  7.5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376980((R)-4-(1-(1-acryloylpyrimidin-3-yl)-4-amino-1H-pyr...)
Affinity DataIC50:  7.70nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376908(US10329300, Example 2 | US9920060, 2)
Affinity DataIC50:  8.30nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376960(US10329300, Example 48 | US11696917, Example 48 | ...)
Affinity DataIC50:  8.5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376921(US10329300, Example 15 | US11696917, Example 15 | ...)
Affinity DataIC50:  8.60nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376942(US10329300, Example 30 | US11696917, Example 30 | ...)
Affinity DataIC50:  8.70nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376914(US10329300, Example 8 | US11696917, Example 8 | US...)
Affinity DataIC50:  9.20nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376981(US11696917, Example 69 | US9920060, 69)
Affinity DataIC50:  9.20nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376944(US10329300, Example 32 | US11696917, Example 32 | ...)
Affinity DataIC50:  9.30nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376925(US10329300, Example 19 | US11696917, Example 19 | ...)
Affinity DataIC50:  10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376915(US10329300, Example 9 | US11696917, Example 9 | US...)
Affinity DataIC50:  10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376907(US10329300, Example 1 | US9920060, 1)
Affinity DataIC50:  10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376950(US10329300, Example 38 | US11696917, Example 38 | ...)
Affinity DataIC50:  10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376982(US11696917, Example 70 | US9920060, 70)
Affinity DataIC50:  10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376922(US10329300, Example 16 | US11696917, Example 16 | ...)
Affinity DataIC50:  10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376983(US10329300, Example 71 | US11696917, Example 71 | ...)
Affinity DataIC50:  11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376984(US11696917, Example 72 | US9920060, 72)
Affinity DataIC50:  11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376949(US10329300, Example 37 | US9920060, 37)
Affinity DataIC50:  11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376970((R)-4-(1-(1-acryloylpyrrolidin-3-yl)-4-amino-1H-py...)
Affinity DataIC50:  11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376946(US10329300, Example 34 | US11696917, Example 34 | ...)
Affinity DataIC50:  11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376911(US10329300, Example 5 | US9920060, 5)
Affinity DataIC50:  11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376910(US10329300, Example 4 | US9920060, 4)
Affinity DataIC50:  12nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376973((R)-1-(1-acryloylpyrrolidin-3-yl)-4-amino-N-(4-(2-...)
Affinity DataIC50:  13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376964(US10329300, Example 52 | US11696917, Example 52 | ...)
Affinity DataIC50:  13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376916(US10329300, Example 10 | US11696917, Example 10 | ...)
Affinity DataIC50:  13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376919(US10329300, Example 13 | US11696917, Example 13 | ...)
Affinity DataIC50:  13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376926(US10329300, Example 20 | US11696917, Example 20 | ...)
Affinity DataIC50:  13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376943(US10329300, Example 31 | US11696917, Example 31 | ...)
Affinity DataIC50:  13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376989(US10329300, Example 77 | US11696917, Example 77 | ...)
Affinity DataIC50:  13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376955(US10329300, Example 43 | US11696917, Example 43 | ...)
Affinity DataIC50:  14nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376990(1-((3R,5S)-1-acryloyl-5-methylpyrrolidin-3-yl)-4-a...)
Affinity DataIC50:  14nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376965(US10329300, Example 53 | US11696917, Example 53 | ...)
Affinity DataIC50:  14nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376947(US10329300, Example 35 | US11696917, Example 35 | ...)
Affinity DataIC50:  16nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376987(US10329300, Example 75 | US11696917, Example 75 | ...)
Affinity DataIC50:  16nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376986(US10329300, Example 74 | US11696917, Example 74 | ...)
Affinity DataIC50:  17nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM376991(US9920060, 79)
Affinity DataIC50:  17nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 80 total ) | Next | Last >>
Jump to: